Etonitazene 5-acetyl analogue
Etonitazene 5-acetyl analogue is a synthetic opioid that is part of the benzimidazole family. It is an analogue of etonitazene, which is itself a potent analgesic.
Chemistry[edit]
Etonitazene 5-acetyl analogue is a synthetic opioid that is structurally related to etonitazene. It is a benzimidazole derivative, which means it contains a benzimidazole ring in its chemical structure. The 5-acetyl group is attached to the benzimidazole ring, which differentiates it from other etonitazene analogues.
Pharmacology[edit]
Like other opioids, etonitazene 5-acetyl analogue acts on the mu-opioid receptor in the brain to produce its analgesic effects. It is believed to be a potent agonist of this receptor, although the exact potency is not known. The mu-opioid receptor is responsible for the pain-relieving effects of opioids, as well as their potential for addiction and dependence.
Effects[edit]
The effects of etonitazene 5-acetyl analogue are similar to those of other opioids. These can include analgesia, sedation, euphoria, and respiratory depression. However, due to its potency, it may also have a higher risk of overdose and dependence than other opioids.
Legal Status[edit]
Etonitazene 5-acetyl analogue is a controlled substance in many countries due to its potential for abuse and addiction. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act.
See Also[edit]
References[edit]
Etonitazene 5-acetyl analogue[edit]
-
Etoacetazene structure
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
